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Background: A novel in vitro system was employed to investigate liver tissue respiration (mitochondrial O2
consumption) in mice treated with concanavalin A (Con A). This study aimed to investigate hepatocyte
bioenergetics in this well-studied hepatitis model.
Methods: C57Bl/6 and C57Bl/6 IFN-γ−/− mice were injected intravenously with 12 mg ConA/kg. Liver specimens
were collected at various timepoints after injection and analyzed for cellular respiration and caspase activation.
Serum was analyzed for interferon-gamma (IFN-γ) and aminotransferases. Fluorescence activated cell sorting
analysis was used to determine the phenotype of infiltrating cells, and light and electron microscopy were used to
monitor morphological changes. Phosphorescence analyzer that measured dissolved O2 as function of time was
used to evaluate respiration.
Results: In sealed vials, O2 concentrations in solutions containing liver specimen and glucose declined linearly with
time, confirming zero-order kinetics of hepatocyte respiration. O2 consumption was inhibited by cyanide,
confirming the oxidation occurred in the respiratory chain. Enhanced liver respiration (by ≈68%, p<0.02) was noted
3 hr after ConA treatment, and occurred in conjunction with limited cellular infiltrations around the blood vessels.
Diminished respiration (by ≈30%, p=0.005) was noted 12 hr after ConA treatment, and occurred in conjunction
with deranged mitochondria, areas of necrosis, and prominent infiltrations with immune cells, most significantly,
CD3+NKT+ cells. Increases in intracellular caspase activity and serum IFN-γ and aminotransferase levels were noted
3 hr after ConA treatment and progressed with time. The above-noted changes were less pronounced in C57Bl/6
IFN-γ−/− mice treated with ConA.
Conclusions: Based on these results, liver tissue bioenergetics is increased 3 hr after ConA exposure. This effect is
driven by the pathogenesis of the disease, in which IFN-γ and other cytokines contribute to. Subsequent declines
in liver bioenergetics appear to be a result of necrosis and active caspases targeting the mitochondria within
hepatocytes.
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The term “cellular bioenergetics” describes the biochemical
processes involved in energy metabolism (energy conver-
sion or transformation), and the term “cellular respiration”
(mitochondrial oxygen consumption) describes the delivery
of metabolites and oxygen (O2) to the mitochondria, the* Correspondence: ericb@uaeu.ac.ae; asouid@uaeu.ac.ae
2Department of Anatomy, College of Medicine and Health Sciences, United
Arab Emirates University, Al Ain, Abu Dhabi, United Arab Emirates (UAE)
3Department of Pediatrics, College of Medicine and Health Sciences, United
Arab Emirates University, Al Ain, Abu Dhabi, United Arab Emirates (UAE)
Full list of author information is available at the end of the article
© 2013 Al-Shamsi et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the oroxidation of reduced metabolic fuels with the passage of
electrons to O2, and the synthesis of ATP. Impaired cellu-
lar bioenergetics or respiration thus entails an interference
with any of these metabolic processes.
Concanavalin A (ConA) is a plant lectin from seeds of
Canavalia ensiformis [Jack bean] that serves as a poly-
clonal T-cell mitogen and is also used to induce hepatitis
in mice. Murine ConA-induced hepatitis is a well-studied
model that mimics human liver viral infections [1,2]. The
liver injury is typically noted within 3 hr of intravenous
injection of ConA (12 mg/kg) and progresses with time
[2]. Activation and recruitment of natural killer T (NK T)ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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events that, in turn, lead to secretion of inflammatory
cytokines, such as interferon-γ (IFN-γ), tumor necrosis
factor (TNF)-α, interleukin (IL)-12, and IL-18 [3]. This
biochemical burst of inflammatory mediators targets mul-
tiple organs, including the liver. Its outcome is a hepato-
toxicity that is characterized by mononuclear cellular
infiltration and foci of necrosis [4].
The potential role of NK T cells in the pathogenesis of
ConA-induced hepatitis is confirmed by the observation
that mice lacking NK T cells and those treated with anti-
IFN-γ antibody (to counter this essential inflammatory
mediator released by NK T cells) are both resistant to
ConA-induced hepatitis. In addition, targeting NK T
cells with glucocerebroside, a naturally occurring glycoli-
pid that inhibits NK T cell proliferation, ameliorates
ConA-induced hepatitis [5]. These findings suggest the
pathological outcome of the liver in ConA-treated ani-
mals relies on initial activation of innate immune com-
ponents, such as NK T cells, followed by subsequent
activation and recruitment of effector immune cells,
including macrophages and T-cells. We confirm here
that the pathology of concanavalin A-induced hepatitis
is dependent on activated immune cells especially NK T
cells and the secretion of cytokines, including IFN-γ, and
mice in which the cytokine is genetically deleted develop
a milder form of the disease.
ConA-induced hepatitis is associated with caspase activa-
tion [6]. Caspase-3, a cysteine aspartate-directed protease
and a family member of the IL-1β-converting enzyme
(ICE), is the key executer of apoptosis. This enzyme is
involved in proteolysis of several proteins, including poly
(ADP ribose) polymerase; it cleaves at the C-terminal to
Asp216 in the DEVD (asp-glu-val-asp) sequence. This
4-amino-acid motif has been utilized for the highly-specific
caspase-3 substrate, Ac-DEVD-AMC (N-acetyl-DEVD-7-
amino-4-methyl-coumarin). Caspase-3 cleaves the tetra-
peptide between D and AMC, releasing the fluorogenic
moiety 7-amino-4-methylcoumarin (AMC) that can be
separated on HPLC and detected by fluorescence [7].
The status of liver tissue mitochondrial O2 consump-
tion in ConA-induced hepatitis is unknown. In this
study, compound alterations in liver tissue respiration
were noted early in the course of the induced hepatitis.
The inflammatory cytokines, including IFN-γ appear to
contribute to these deleterious changes in hepatocyte
energy metabolism.
The effect of inflammatory bursts on hepatocyte
bioenergetics is unknown, especially in ConA-induced
hepatitis. In theory, inflammatory cytokines are expected
to enhance cellular energy metabolism; however, this
phenomenon has not yet been investigated and answers
are needed. This present study attempts to address some
of these queries. Measuring liver tissue respiration, usingthe principle that O2 quenches the phosphorescence of
palladium (Pd) II-meso-tetra-(4-sulfonatophenyl)-tetra-
benzoporphyrin, has been recently reported [8-10]. This
analytical tool is used here to monitor liver tissue O2
consumption in ConA-induced hepatitis in mice.
Methods
Reagents
The Pd(II) complex of meso-tetra-(4-sulfonatophenyl)-
tetrabenzoporphyrin (Pd phosphor) was obtained from
Porphyrin Products (Logan, UT). Dactinomycin (actino-
mycin D, MW ≈ 1255) was purchased from Merck
(Whitehouse Station, NJ). A lyophilized powder of caspase
inhibitor I (zVAD-fmk, MW ≈467.5) was purchased from
Calbiochem (La Jolla, CA). Ac-DEVD-AMC (MW ≈729.6)
and caspase-3 (molecular mass ≈30.5 kDa, heterodimer
active human recombinant) were purchased from Axxora
LLC (San Diego, CA). Glucose [anhydrous], ConA (from
Canavalia ensifomis, Jack bean, Type IV-S), bovine serum
albumin (free of endotoxin and fatty acids), and remaining
reagents were bought from Sigma-Aldrich (St. Louis, MO).
Dactinomycin solution was made fresh in dH2O; its
concentration was determined by absorbance at 440 nm,
using an extinction coefficient of 24,450 M-1 • cm-1 [7].
The zVAD-fmk solution (2.14 mM) was made by
dissolving 1.0 mg of zVAD-fmk in 1.0 ml of dimethyl
sulfoxide and stored at −20°C. The Ac-DEVD-AMC cas-
pase substrate was dissolved in dimethyl sulfoxide at a
concentration of 6.85 mM and stored at −20°C in small
aliquots. Phosphate-buffered saline (PBS) with glucose
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4
mM KH2PO4, and 5 mM glucose; pH 7.4) was made
fresh. ConA (5 mg) was suspended in 3 ml sterile PBS
(f/c = ~1.67 mg/ml); aliquots were stored at −20°C. Pd
phosphor solution (2.5 mg/ml = 2 mM) was prepared in
dH2O and stored in aliquots at −20°C. NaCN solution
(1.0 M) was prepared in dH2O; the pH was adjusted
to ~7.0 with 12 N HCl and stored at −20°C.
Mice
Male C57Bl/6 and C57Bl/6 IFN-γ−/− mice (8-12-wk-old;
weight ≈18-22 g) used in this study were maintained at
an animal facility that was in compliance with NIH
guidelines (http://grants.nih.gov/grants/olaw/references/
phspol.htm). The mice were purchased from The Jackson
Laboratory (Bar Harbor, ME). All mice were housed in
rooms maintained at 22°C with ~60% relative humidity
and a 12-hr light/dark cycle. All mice had ad libitum
access to standard rodent chow and filtered water. All
protocols here received approval from the Animal Ethics
Committee-United Arab Emirates University - College
of Medicine and Health Sciences.
For these studies, experimental mice were given a single
intravenous injection (12 mg/kg body weight in a total
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vein. At 0–12 hr after the treatment, mice were eutha-
nized by intra-peritoneal injection of 100 μl/10 g (BW) of
urethane (using 20% solution [w/v] in 0.9% NaCl) and
blood was collected from the sino-orbital orifice; serum
was subsequently prepared by standard protocols. At
necropsy, liver specimens were collected for analyses.
Liver tissue
Liver specimens (18–30 mg/mouse) were excised using a
sharp pair of scissors (Moria Vannas Wolg Spring, cat. #
ST15024-10, Cambridge, UK). Following protocols previ-
ously outlined [8,9], the specimens were immediately
immersed in ice-cold oxygenated Krebs-Henseleit buffer
(115 mM NaCl, 25 mM NaHCO3, 1.23 mM NaH2PO4, 1.2
mM Na2SO4, 5.9 mM KCl, 1.25 mM CaCl2, 1.18 mM
MgCl2, and 6 mM glucose [pH 7.2]), weighed and then
placed in 1.0 ml Krebs buffer containing 0.5% fat-free
bovine albumin and 3 μM Pd phosphor for O2 measure-
ments. Unless otherwise noted, the time period between
specimen collection and start of O2 measurement was < 5
min. Where stated, specimens were incubated in vitro at
37°C in Krebs-Henseleit solution gassed with 95% O2:5%
CO2 prior to O2 measurements.
Specimens were also fixed in 4% phosphate-buffered
paraformaldehyde and embedded in paraffin wax blocks.
Sections of the fixed liver pieces (of 5–7 μm thickness)
were stained with haematoxylin and examined under a
light microscope. Sections of the harvested liver were
also placed in Karnovsky’s solution and processed for
electron microscopy [8].
Oxygen measurements
A phosphorescence oxygen analyzer was used to monitor
O2 consumption by liver specimens [8,9]. O2 detection was
performed with the aid of Pd phosphor that had an
absorption maximum at 625 nm and a phosphorescence
maximum at 800 nm. Samples were exposed to light
flashes (600 per min) from a pulsed light-emitting diode
array with peak output at 625 nm (OTL630A-5-10-66-E,
Opto Technology, Inc., Wheeling, IL). Emitted phosphor-
escent light was detected by a Hamamatsu photomultiplier
tube (928) after first passing it through a wide-band inter-
ference filter centered at 800 nm. The amplified phosphor-
escence decay was digitized at 1.0 MHz by a 20-MHz A/D
converter (Computer Boards, Inc., Mansfield, MA).
A program was developed using Microsoft Visual Basic
6, Microsoft Access Database 2007, and Universal Library
components (Universal Library for Measurements Com-
puting Devices; http://www.mccdaq.com/daq-software/
universal-library.aspx). It allowed direct reading from the
PCI-DAS 4020/12 I/O Board (PCI-DAS 4020/12 I/O
Board; http://www.mccdaq.com/ pci-data-acquisition/PCI-
DAS4020-12.aspx). The pulse detection was accomplishedby searching for 10 phosphorescence intensities >1.0 volt
(by default). Peak detection was accomplished by searching
for the highest 10 datapoints of a pulse and choosing the
datapoint closest to the pulse decay curve [10].
The phosphorescence decay rate (1/τ) was character-
ized by a single exponential; I = Ae-t/τ, where I = Pd
phosphor phosphorescence intensity. The values of 1/τ
were linear with dissolved O2: 1/τ = 1/τ
o + kq[O2], where
1/τ = the phosphorescence decay rate in the presence of
O2, 1/τ
o = the phosphorescence decay rate in the
absence of O2, and kq = the second-order O2 quenching
rate constant in sec-1 • μM-1 [11].
Liver tissue respiration was measured at 37°C in 1 ml
sealed vials. Mixing was carried out with the aid of
parylene-coated stirring bars. In vials sealed from air, [O2]
decreased linearly with time, indicating the kinetics of mito-
chondrial O2 consumption was zero-order. The rate of
respiration (k, in μM O2/min) was thus the negative of the
slope d[O2]/dt. Sodium cyanide (NaCN) inhibited respir-
ation, confirming that O2 was being consumed in the mito-
chondrial respiratory chain (Additional file 1: Figure S1).
Calibration with β-glucose plus glucose oxidase
The calibration reaction contained PBS with 3 mM Pd
phosphor, 0.5% fat-free albumin, 50 mg/ml glucose oxi-
dase and various concentrations of β-glucose. The values
of 1/t were linear with [β-glucose]; the value of kq was
the negative of the slope (kq = 101.1 sec
-1 • μM-1). The
value of 1/τ for air-saturated solution (without glucose)
was 28,330 sec-1 (coefficient of variation, Cv = 12%) and
for O2-depleted solution (with 500 mM β-glucose, 1/τo)
2,875 sec-1 (Cv = 1%). The high values of Cv for the
air-saturated solutions were due to the lower phosphor-
escence intensities with high [O2] (little light reaching
the photomultiplier tube). O2 concentration was calcu-
lated using, 1/τ = 1/τo + kq[O2].
Dissolved O2 is expressed in mm Hg, ml O2/L, mg O2/
L, or mmol/L (mM). For conver-sion: A partial pressure
of oxygen (PO2) of 1.0 mm Hg = 0.03 ml O2/L; 1.0 ml O2/
L = 1.4276 mg O2/L; 1.0 mg O2/L = 1000/32 μM. In fresh-
water at 760 mm Hg and 20°C, dissolved [O2] is 9.1 mg/L,
or 284 μM. Using a Clark electrode, the PO2 of our reac-
tion mixture (PBS with 10 mM glucose, 3.0 μM Pd phos-
phor and 0.5% fat-free bovine serum albumin) was 170.5
[± 6.6] mm Hg (n = 4), or 228 [± 9] μM. The 56 mm Hg
difference between [O2] in freshwater and the Pd solution
reflects the effect of salinity on dissolved O2.
Serum IFN-γ and aminotransferases
Serum IFN-γ levels were determined using a sandwich
ELISA DuoSet ELISA Develop-ment (mouse IFN-γ) kit
(R&D Systems, Minneapolis, MN), according to manu-
facturer protocols. IFN-γ concentrations (in pg/ml) were
extrapolated from a standard curve generated in parallel
Figure 1 Liver respiration 3 hr after ConA injection (immediately post-tissue collection and after in vitro incubation). C57Bl/6 wild-type
mice were injected either with PBS (Panel A) or with 12 mg ConA/kg (Panel B). Two liver specimens were then collected per mouse at 3 hr post-
injection; minute zero corresponds to the time of sacrifice of an animal. For untreated mice, one specimen (25 mg) was run at t = 4 (immediately post-
collection) and one (27 mg) at t = 83 min. For the treated mice, one specimen (20 mg) was run at t = 4 (immediately post-collection) and one (24 mg)
at t = 49 min. The lines shown are linear fits. Rates of respiration (kc, in μM O2 min-1 • mg-1) and R2 values are shown at the bottom of the runs.
Figure 2 Time-dependent changes in liver respiration in ConA hepatitis in C57Bl/6 mice. C57Bl/6 mice (wild-type) were injected with PBS
or 12 mg ConA/kg. Liver tissue specimens were then collected at the indicated timepoints and processed for O2 measurements. Values shown
are the mean (± SD), with the values of “n” underneath each timepoint. The p-values at 3 and 12 hr (compared to 0 hr) are also shown;
remaining values were insignificant.
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Table 1 Liver tissue respiration in samples harvested




mean ± SD (n) range
C57Bl\6 (wild-type) PBS (300 μl) 0.26 ± 0.04 (5) 0.22 - 0.32
ConA (12 mg/kg) *0.18 ± 0.03 (5) 0.13 - 0.20
“n” represents number of independent experiments. *Value significantly
different from control at p ≤ 0.005.
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sitivity of the kit was 20 pg/ml.
Serum alanine aminotransferase (ALT) activity was
determined on a Beckman Coulter SynchronW System
(Brea, CA); 150 μl serum/mouse were used in a reaction
that contained L-alanine, α-ketoglutarate, NADH and
lactate dehydrogenase. NADH oxidation, calculated from
the change in absorbance at 340 nm, is proportional to
the transaminase activity and the basis for the calcula-
tion of ALT activity/sample. The level of sensitivity of
the assay was 5 IU/L. Serum aspartate aminotransferase
(AST) activity was determined as above, in a reaction
that contained L-aspartate, α-ketoglutarate, NADH, and
malate dehydrogenase. The level of sensitivity of the
assay was 5 IU/L.
Intracellular caspase activity
Liver specimens (40–55 mg) were incubated at 37°C in
oxygenated KH buffer containing 74 μM Ac-DEVD-AMC
with and without 43 μM zVAD-fmk (final volume = 0.5 ml)
for 30 min. At the end of the incubation period, the suspen-
sion was sonicated on ice for 60 sec and passed 10 times
through a 27-gauge needle. The cleavage reaction was
quenched with tissue disruption, as caspases became in-
active due to the dilution. The supernatants were then col-
lected by centrifugation (~12300 × g for 15 min, 25°C),
separated via HPLC and analyzed for free AMC as
described below [7].
HPLC
The analysis was performed on a Waters 1525 reversed-
phase HPLC system (SpectraLab Scientific Inc, Alexandria,
VA) that consisted of a manual injector, pump, and fluor-
escence detector. The excitation wavelength used wasTable 2 Liver tissue respiration in tissues collected from





C57Bl\6 PBS (180 μl) 0.27 ± 0.13 (11)
C57Bl\6 ConA (12 mg/kg) 0.26 ± 0.07 (3)
C57Bl\6 IFN-γ−/− ConA (12 mg/kg) 0.25 ± 0.10 (3)
“n” represents number of independent experiments. Values shown are mean ± SD.380 nm and the emission wavelength 460 nm. Solvent A
was HPLC-grade CH3CN:H2O [1:3, v/v], and Solvent B
was dH2O (isocratic). The Ultrasphere IP column (4.6 ×
250 mm, Beckman, Brea) was operated at 25°C at 1.0 ml/
min (0.5 ml/min of each pump). The run time was 30 min.
Phenotyping of infiltrating mononuclear cells by
fluorescence activated cell sorting analysis (FACS) analysis
Liver fragments were placed in RPMI with 5% fetal calf
serum (FCS; Hyclone, Logan, UT) and 25 mM HEPES,
and passed through 200-gauge stainless steel mesh. The
pellets were then collected by centrifugation (~500 × g at
4°C for 10 min), suspended in 40% PercolW, and layered on
the top of 70% PercolW. The solutions were then centri-
fuged at ~100 × g and 25°C for 20 min. The mononuclear
cells were collected from the interface, washed twice with
RPMI, and re-suspended in RPMI at 3 × 105/ml.
For immunophenotyping, the fluorescent-labeled anti-
bodies fluorescein isothiocyanate (FITC)-conjugated rat
anti-mouse CD3, CD4, and CD45 and phycoerythrin
(PE)-conjugated rat anti-mouse CD8, NK T, and CD11b
were used (all were purchased from eBioscience, San
Diego, CA). To avoid non-specific binding, 1 × 106 cells/
mouse were incubated with 20% FCS for 10 min at 4°C.
The cells were then gently washed with PBS supplemen-
ted with 5% FCS and the resultant pellet treated with
100 μl aliquots (from 3 μg/ml stocks) each of a given pair
of antibodies, i.e., FITC-anti-CD4 + PE-anti-CD8, FITC-
anti-CD3 + PE-anti-NK/NKT, or FITC-anti-CD45 + PE-
anti-CD11b. The cells were then incubated for 35 min at
4°C in the dark. Thereafter, the cells were washed twice
with PBS-FCS and then re-suspended at 106 cells/tube in
0.5 ml PBS-FCS. Samples were then analyzed via flow
cytometry using a FACSort system (Becton Dickinson,
Franklin Lakes, NJ) and associated CellQuest software. A
minimum of 10,000 events per sample were acquired.
Statistical analysis
The Student’s t-test of difference of means was used to
compare treated and untreated samples. The threshold
of significance was taken to be p < 0.05.
Results
Hepatocyte oxygen consumption in C57Bl/6 mice treated
with ConA
Figure 1 depicts a representative experiment of hepatocyte
respiration in ConA-treated and untreated C57Bl/6 mice.
One mouse was injected with PBS (Panel A) and one with
12 mg ConA/kg per body weight (Panel B). Two liver
specimens were collected from each mouse 3 hr after
injection. For the untreated mouse, one specimen was run
immediately and one after ~83 min of in vitro incubation
at 37°C in Krebs-Henseleit solution gassed with 95% O2:5%
CO2. The rate of respiration (kc, μM O2 min
-1 • mg-1) in
Figure 4 Serum IFN-γ and ALT in untreated and ConA-treated
C57Bl/6 mice. C57BL/6 mice were injected with PBS or 12 mg ConA/
kg. Serum was collected 3, 6, and 12 hr post- injection and processed
for IFN-γ. IFN-γ values shown are mean (± SD) of three determinations
for each sample (n = 3 animals/sample). ALT activities at 0, 3, 6, and 12
hr are from a single experiment (see Results).
Figure 3 Time-dependent changes in liver respiration in ConA hepatitis in C57Bl/6 IFN-γ−/− mice. Mice were injected with 20 mg ConA/kg
and liver specimens (24–29 mg) were collected for O2 measurements at 3, 6, and 12 hr post-injection. Control mice were injected with PBS. Rates
of respiration (kc, in μM O2 min-1 • mg-1) are shown at the bottom of the runs. All four runs were performed on one instrument. One animal was
sacrificed at-a-time in the following sequence: 12 hr post-injection, 3 hr post-injection, PBS, and then 6 hr post-injection. Minute zero corresponds
to sacrifice of the first animal.
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specimens in vitro [8,9]. For the treated mouse, one speci-
men was also run immediately post collection and one
after ~49 min of in vitro incubation as above. The values
of kc were 0.42 (2-fold increment) and 0.18 (similar to the
control) respectively. These results demonstrate acceler-
ated rate of liver tissue O2 consumption 3 hr after ConA
injection. In another experiment, the values of kc for the
untreated mouse were 0.20 at t = 5 min (immediately post
specimen collection) and 0.24 at t = 83 min (after 83 min
incubation in vitro as above); the corresponding values for
the treated mouse were 0.34 at t = 3 min (a 70% increment)
and 0.14 at t = 59 min. In a third experiment, the values of
kc for the untreated mouse were 0.25 at t = 5 min and 0.23
at t = 58 min; corresponding values for the treated mouse
were 0.34 at t = 5 min (36% increment) and 0.20 at t = 75
min. Thus, for untreated mice, values of kc (mean ± SD)
were 0.22 ± 0.02 (n = 6). For treated mice, values of kc for
specimens run immediately were 0.37 ± 0.05 (n = 3, a 68%
increase, p = 0.015) and for specimens incubated in vitro
before the run, 0.17 ± 0.03 (n = 3, a 54% less, p = 0.005).
In a total of eight independent experiments, the values of
kc in untreated mice were 0.234 ± 0.024 (n = 8) and in trea-
ted mice 3 hr after ConA injection (12 mg/kg) 0.300 ±
0.066 (n = 8, p < 0.05). The variability in the values of kc in
Figure 5 (See legend on next page.)
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Figure 5 Liver tissue caspase activation in untreated and ConA-treated C57Bl/6 mice. C57BL/6 mice were injected with (A) PBS or (B-D) 12
mg ConA/kg. Liver specimens were collected (B) 3, (C) 6, or (D) 12 hr post-injection and processed immediately for caspase activity. For each
condition, liver specimens were incubated at 37°C in oxygenated KH buffer in the presence of 74 μM Ac-DEVD-AMC with (dashed line) and
without (solid line) 43 μM zVAD-fmk for 30 min. The cleavage reaction was quenched with tissue disruption. The supernatants were separated via
HPLC and analyzed for Ac-DEVD-AMC (Rt, ~3 min) and free AMC (Rt, ~18 min) peaks as described in the Materials and Methods. In Panel E, liver
specimens were treated in vitro with 8 μM dactinomycin for 60 min prior to the addition of Ac-DEVD-AMC with (dashed line) and without
(solid line) zVAD-fmk.
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injected mice compared to ~10% in untreated mice) likely
reflected the heterogeneity of the liver involvement and the
variation of its progress with time.
Changes in liver tissue respiration during the course of
ConA-induced hepatitis are summarized in Figure 2. As
discussed above, the rate of respiration (kc) significantly
increased at 3 hr (p < 0.02) and decreased at 12 hr
(p = 0.005, see also Table 1). By contrast, the values of kc at
1, 2, and 6 hr after ConA injection did not significantly dif-
fer from untreated mice (also see Table 2). Liver tissue res-
piration was not altered by in vitro addition of ConA
(Additional file 1: Figure S2).
Hepatocyte oxygen consumption in C57Bl/6 IFN-γ−/− mice
treated with ConA/kg
C57Bl/6 IFN-γ−/− mice were injected with 20 mg
ConA/kg or PBS and then liver pieces were collectedA B
D E
Figure 6 Micrographs of hematoxylin-stained liver sections from untr
Samples are representative of those from (A, B, C) wild-type and from (D,
mg ConA/kg. Livers were then collected at (A, D) 3, (B, E) 6, and (C, F) 12
wild-type mice at 3 and (more profusely) 6 hr (arrow), and the solitary cells
around vessels and sinusoids in both strains. At 12 hr post-injection, areas o
liver of wild-type mice, but livers of IFN-γ−/− mice remained unaffected. Bar3, 6, and 12 hr post-injection. The mean kc value
(in μM O2 min
-1 • mg-1) for uninjected mouse was
0.27. The corresponding kc values for injected mice at
3, 6, and 12 hr post-injection were 0.19, 0.22, and
0.22, respectively (Figure 3 and Table 2). Of note,
additions of exogenous IFN-γ (10, 50 or 100 ng/mL)
resulted in inhibition of liver tissue respiration (Additional
file 1: Figure S3).Serum IFN-γ in C57Bl/6 mice treated with ConA
Serum IFN-γ levels were determined in untreated and
ConA-treated (12 mg/kg) C57Bl/6 mice at 0, 3, 6, and
12 hr post-injection. The results of three independent
experiments are shown in Figure 4. Relative to the values
seen in untreated animals, elevated levels of IFN-γ were
noted at 3 hr after ConA injection, and these increased
with time.C
F
eated and ConA-treated C57Bl/6 and C57Bl/6 IFN-γ−/− mice.
E, F) IFN-γ−/− C57Bl/6 mice, each of which had been injected with 12
hr post-injection. Note the accumulation of mononuclear cells in the
in the IFN-γ−/− mice (even 6 hr after injection). Infiltration is found







Figure 7 Electron micrographs of hepatocytes from untreated
and ConA-treated C57Bl/6 mice. Hepatocytes were obtained from
(A) normal untreated and ConA-injected C57Bl/6 mice (B) 3 and (C)
6 hr post-injection. A representative micrograph is shown for each
timepoint. Note the nuclei and mitochondria in each of the
micrographs are normal. Bar = 0.3 μm.
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treated with ConA
Serum ALT activity was determined in untreated and
ConA-treated (12 mg/kg) C57Bl/6 mice at 0, 3, 6, and 12
hr post-injection. Elevated levels of ALT were noted at 3 hr
after ConA and these increased with time (Figure 4). In
three independent experiments, serum ALT levels 12 hr
after ConA were 440 ± 393 IU/L (mean ± SD, n = 3) and
AST 768 ± 528 (n = 3).
For C57Bl/6 IFN-γ−/− mice, ATL activities were 45, 96,
and 32 IU/L at the 0, 3 and 6 hr time points, respectively.
The corresponding values for AST were 157, 259, and 228
IU/L. At 12 hr, the values of ALT were 172 ± 154 IU/L
(n = 3) and AST 394 ± 198 IU/L (n = 3).
Serum ALT activities in PBS-treated C57Bl/6 mice at 0
and 12 hr were, respectively, 30 and 30 U/L; serum IFN-
γ levels in PBS-treated C57Bl/6 mice at 0 and 12 hr were
non-measurable. Serum ALT activities in PBS-treated
C57Bl/6 IFN-γ−/− mice at 0 and 12 hr were, respectively,
35 and 46 U/L.
Caspase activation in C57Bl/6 mice treated with ConA
Caspase activity in liver tissue was monitored in untreated
and ConA-treated (12 mg/kg) mice at 3, 6, and 12 hr
post-injection, using the caspase-3 substrate analogue Ac-
DEVD-AMC. Liver specimens were incubated with 74
μM Ac-DEVD-AMC in the presence and absence of the
pan-caspase inhibitor zVAD-fmk. Caspases cleaved Ac-
DEVD-AMC, releasing the fluorogenic moiety AMC;
post-sample disruption, AMC was separated on HPLC
(Rt ~18 min) and detected by fluorescence.
AMC peak was neither detected in the untreated
mouse (Figure 5A) nor in the ConA-treated mouse at 3
hr (Figure 5B). By contrast, an AMC peak was detected
at 6 and 12 hr after ConA injection. At 6 hr (Figure 5C),
the AMC peak area (arbitrary units) without zVAD-fmk
was 1,417,450 and with zVAD-fmk was 691,348 (~51%
inhibition). At 12 hr (Figure 5D), the AMC peak area
without zVAD-fmk was 2,028,388 and with zVAD-fmk
1,252,429 (~38% inhibition). These results demonstrate
rapid uptake and hydrolysis of Ac-DEVD-AMC by active
caspases in hepatocytes. Residual caspase activity in the
presence of zVAD-fmk was due to the simultaneous
addition of Ac-DEVD-AMC (added in excess) and
zVAD-fmk. The free AMC moieties were negligible in
experiments where Ac-DEVD-AMC was added 10 min
after addition of zVAD-fmk (data not shown). In another
Figure 8 Electron micrographs of sections of murine liver taken 12 hr after intravenous injection of 12 mg ConA/kg. Representative
samples shown are from C57Bl/6 (B, D) and C57Bl/6 IFN-γ−/− (A, C) mice. Note the areas of fibrosis (**) and deranged mitochondria (★) in the
liver of C57Bl/6 mice. With the exception of fatty infiltrates (▲), the liver of the C57Bl/6 IFN-γ−/− mice appears normal with intact mitochondria
(m). Bars: A-B = 0.5 μm; C-D = 0.2 μm.
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tected at 3 hr and increased linearly at 12 hr (R2 >0.999
and >0.995).
For comparison, liver tissue specimens were also trea-
ted in vitro with 8 μM dactinomycin, a cytotoxic agent
that intercalates between DNA base pairs and activates
caspases [7]. The AMC peak area in the presence of
dactinomycin alone was 6,504,578 and in the presence
of dactinomycin + zVAD-fmk was 1,427,361 (78% inhib-
ition, Figure 5E).
Light and electron microscopy of tissues from C57Bl/6
and C57Bl/6 IFN-γ−/− mice
Figure 6 shows the liver histology in ConA-injected
(12 mg/kg) C57Bl/6 and C57Bl/6 IFN-γ−/− mice at 3, 6
and 12 hr. In C57Bl/6 mice, mononuclear cell accumula-
tion around blood vessels was noted 3 and 6 hr after the
ConA administration. More prominent mononuclear cell
infiltration around blood vessels and into the tissues and
areas of necrosis were noted 12 hr after the injection inC57Bl/6, but not in C57Bl/6 IFN-γ−/−, mice. Overall, the
liver architecture was relatively preserved in the C57BL/6
IFN-γ−/− mice.
Electron micrographs of the hepatocytes showed a nor-
mal presence of nuclei and mitochondria in untreated and
ConA-treated (12 mg/kg) C57Bl/6 mice at 3 and 6 hr after
injection (Figure 7).
The histopathology of liver sections obtained from unin-
jected or PBS-injected C57Bl/6 and from uninjected or
PBS-injected C57Bl/6 IFN-γ−/− mice showed an absence
of infiltrations in any of the sections examined and prom-
inent sinusoids in the livers of the PBS-injected hosts from
both strains (Additional file 1: Figure S4).
Electron micrographs of sections of murine liver taken
12 hr after intravascular injection of ConA (12 mg/kg)
from C57Bl/6 and C57Bl/6 IFN-γ−/− mice are shown in
Figure 8. Areas of fibrosis and deranged mitochondria
were prominent in the liver of C57Bl/6 mice. With the
exception of fatty infiltrates, the liver of C57Bl/6 IFN-γ−/−
mice appeared normal - with intact mitochondria.
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Figure 9 (See legend on next page.)
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Figure 9 FACS analysis. Panel 1A (FACS analysis of CD3+CD4+ and CD3+CD8+ cells of liver samples): Representative liver samples from C57Bl/6
wild-type (i and ii) and IFN-γ−/− on C57Bl/6 background (iii and iv) mice 12 hr after injection with 12 mg/kg of ConA. The number of mononuclear cells
per mouse isolated from ConA injected mice was 1.5 × 106 (C57Bl/6) and 1.8 × 106 (C57Bl/6 IFN-γ−/−), respectively. The number of mononuclear cells
per mouse isolated from uninjected C57Bl/6 mice was 5.0 × 104 (v and vi). The values in the upper right corners (i-vi) are percents of CD4+ or CD8+ T
cells. Panel 1B: The numbers (×106) of CD4+ (lines) and CD8+ (dots) T cells for wild-type (WT) and IFN-γ−/− mice are shown. There were no significant
differences between the numbers of CD4+ or CD8+ T cells isolated from the two strains. As expected, there was near absence of these cells in the
uninjected mice. Panel 2A-B (FACS analysis of CD3+NKT+ and CD45+CD11b+ cells of liver samples). Note the significant number of NKT+ cells
(lines) present in the WT mice compared to the IFN-γ−/− mice (p<0.005). There was no significant difference between the numbers of CD11b+ cells
(dots) isolated from the two strains. As expected, there was near absence of these cells in the uninjected mice.
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FACS analyses of liver homogenates prepared from
C57Bl/6 and C57Bl/6 IFN-γ−/− mice were performed to
characterize the phenotype of cellular infiltrates 12 hr
after intravenous injection of ConA (12 mg/kg). As
shown in Figure 9, T-cells (CD4+, CD8+) and macro-
phages (CD45+CD11b+) were present in both strains.
NKT cells (CD3+NKT+), on the other hand, were signifi-
cantly present only in the wild-type mice (p < 0.005). Of
note, much lower number of cells was present in the
uninjected C57Bl/6 mice.
Discussion
Concanavalin A (ConA) is a potent inducer of inflamma-
tory cytokines from the innate immune cells. Intravenous
administration of this lectin results in progressive hepatic
inflammation in mice [1,2]. The events commence within
2 hr of ConA treatment, with attachment of leukocytes to
the hepatic endothelium and activation of NK cells and
macro-phages. At about 8 hr, lymphocytes adhere to hepa-
tocytes. At this stage, morphological changes (e.g., cell
surface blebs) on hepatocytes and endothelium - and
recruitment of neutrophils to the vascular lumen - be-
come prominent. In later stages, the sinusoidal surfaces of
hepatocytes show rupture of the cell membrane and loss
of cytoplasm (necrosis) [1,2]. Thus, it appears that the
ConA-induced hepatic injury represents deleterious
effects of inflammatory molecules released by a number of
cellular sources, including Kupffer cells, NK cells, leuko-
cytes, and endothelial cells [12,13].
Changes in liver tissue bioenergetics during the course of
ConA-induced hepatitis have not been previously studied.
It is unknown whether the inflammatory cytokines alter
hepatocyte metabolism (e.g., inducing higher energy ex-
penditure and requirement). A novel finding in this study is
that an increase in hepatocyte O2 consumption is observed
3 hr after ConA injection. This effect is not present in the
C57Bl/6 IFN-γ−/− mice, which has a milder disease. Cyto-
kines, including IFN-γ, typically appear in the serum 2 to 3
hr after ConA administration [14]; the findings here are in
keeping with those earlier studies (Figure 4).
A suppression of ConA-induced hepatitis is noted in
the IFN-γ−/− mice (Figures 6, 8 and Additional file 1:
Figure S3). Nevertheless, the precise mechanism for theup-regulation of hepatocyte mitochondrial O2 consump-
tion by ConA treatment is unknown. This effect was
noted at 3 hr after ConA injection when the inflamma-
tory cells were not yet prominent (Figure 6A).
Ac-DEVD-AMC is a synthetic substrate that enters
the cells rapidly and is cleaved by caspases, yielding the
fluorescent compound AMC [7]. Following cell dis-
ruption, any released AMC is separated via HPLC and
detected by fluorescence with great sensitivity. The re-
duction in AMC peak areas due to the pan-caspase
inhibitor zVAD-fmk confirms that intra-cellular caspases
are responsible for the cleavage. As shown in Figure 5,
the AMC peak was noted 6 hr after ConA injection and
it was significantly reduced by zVAD-fmk; thus, ConA
treatment led to caspase activation. Furthermore, the
noted drop in hepatocyte O2 consumption 6 hr after
ConA administration (see Figure 2) could be due to
caspase-induced inhibition of the mitochondrial func-
tion. The more prominent decrease in hepatocyte respir-
ation at 12 hr after ConA, on the other hand, was
associated with areas of necrosis and deranged mitochon-
dria (see Figures 6 and 8). Of note here, the hepatocyte
nuclei and mitochondria remained relatively preserved 3
and 6 hr after ConA administration to the hosts (Figure 7).
The pathologic changes in ConA-induced hepatitis are
heterogeneous, likely accounting for the variability in the
rate of O2 consumption observed here. Again, the precise
mechanism for this patchy accumulation of inflammatory
cells and focal necrosis is presently unknown.
IFN-γ is a key inflammatory cytokine in ConA-induced
hepatitis [3]. The probable source of IFN-γ is NKT cells
recruited into the liver, whose numbers were found to be
significantly elevated in C57BL/6 mice compared with
their knock-out counterparts 12 hr after ConA injection
(Figure 9) [15-17]. In the studies here, the lack of IFN-γ in
the C57BL/6 IFN-γ−/− mice partially repressed the disease
(Figure 8), even when a higher dose of ConA (20 mg/kg)
was employed. Interestingly, liver tissue respiration was
also less impacted in these mice. The progressive increases
in serum IFN-γ, ALT, AST, and intracellular caspases in
the ConA-treated C57Bl/6 mice emulated the progression
of hepatocyte morphologic changes (confirmed by light
and electron microscopy). Inexplicably, however, the ultra-
structural changes at 3 and 6 hr after injection with ConA
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noted only at 12 hr (Figure 8).
The observed enhancement of hepatocyte respiration in
ConA hepatitis is not a direct action of IFN-γ (Additional
file 1: Figure S3). It is due to the ConA-induced disease, in
which IFN-γ contributes to its pathogenesis. For example,
NKT cells (CD3+NKT+) were significantly present in the
wild-type mice compared to IFN-γ−/− mice (p < 0.005,
Figure 9).
Conclusion
In conclusion, the results of the current studies show
increases in hepatocyte O2 consumption 3 hr after ConA
treatment. This finding appears to reflect higher meta-
bolic energy expenditure early in the course of disease.
Additional file
Additional file 1: Figure S1. Typical runs of liver tissue respiration with
cyanide and glucose oxidase are shown below. NaCN (10 mM) inhibited 82-
86% of liver O2 consumption, confirming that the oxidation occurred in the
mitochondrial respiratory chain. The remaining O2 in the solution was
depleted with the addition of glucose oxidase (50 μg/ml). Figure S2. ConA
did not significantly alter liver tissue respiration in vitro. A representative
experiment is shown below. Briefly, murine liver specimens (4-13 mg) were
incubated in vitro at 37oC with and without 10 μg/ml ConA in KH buffer
(continuously gassed with 95% O2:5% CO2) for up to ~8 hr. Minute zero
corresponds to time of sacrifice of the animal. Samples were alternatively
removed from the incubation solution, rinsed with the same buffer, and
placed in the instrument for O2 measurements at 37
oC. Rates of respiration,
k in μM O2 min-1 and kc in μM O2 min-1 mg-1, are shown at the bottom of
the runs. Similar results were observed with higher ConA concentrations
(data not shown). Figure S3. IFN-γ inhibited liver tissue respiration in vitro.
Liver specimens (~25 mg each) were incubated in vitro at 37oC in KH buffer
continuously gassed with 95% O2:5% CO2. Samples were sequentially
removed from the incubation solution and placed in the oxygen vial for
measurement of respiration. Minute zero corresponds to time of sacrifice of
the animal. At indicated time points, IFN-γ (100, 50 or 10 ng/mL), sodium
cyanide (CN, 10 mM) or glucose oxidase (GO, 5 μg/mL) were added. Rates
of respiration, k in μM O2 min-1, are shown. Figure S4. Micrographs of
hematoxylin-stained paraffin embedded liver sections of uninjected (A) or
PBS (C, at 12 hr) injected C57Bl/6 and uninjected (B) or PBS injected (D, at
12 hr) C57Bl/6 IFNγ−/− mice. Note the absence of infiltrations in any of the
sections and the prominent sinusoids in PBS injected livers of both strains.
Bar = 50 μm.
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